Thorat J D, Wang E C, Lee K K, Seow W T, Ng I
Acute Brain Injury Research Laboratory, Department of Neurosurgery, Tan Tock Seng Hospital, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
J Clin Neurosci. 2008 Feb;15(2):143-8. doi: 10.1016/j.jocn.2006.08.014. Epub 2007 Nov 7.
The aim of this study was to explore the effects of barbiturate coma on cerebral tissue oxygen tension and cerebrovascular pressure reactivity (PRx), as an index of cerebral autoregulation in severe head injury patients. This was a prospective observational clinical study of 12 patients with severe traumatic brain injury, carried out at a tertiary-level neurosurgical intensive care unit between April 2002 and May 2005. All patients received standard neurosurgical intensive care and monitoring. Probes for intracranial pressure (ICP), brain temperature (BT) and brain tissue oxygenation (PTiO2) were inserted into (noncontused) normal-looking white matter. Cerebrovascular PRx was measured as a moving correlation between ICP and arterial blood pressure. Barbiturate coma was instituted when ICP became refractory (ICP>20 mmHg). All data from the multimodal monitoring were digitally extracted and statistically analysed. The mean ICP decreased with barbiturate coma in eight of the 12 patients (75% of the patients), but only four achieved a value below 20 mmHg. Of eight patients with prebarbiturate PTiO2 levels above 10 mmHg, six had a further improvement in oxygenation. Thus, concordant favourable changes in ICP, PRx and PTiO2 with barbiturate coma were seen in those who survived. Effective response to barbiturates can be detected by improved PTiO2 and autoregulation (PRx) in severe head injury patients.
本研究旨在探讨巴比妥类药物昏迷对严重颅脑损伤患者脑组织氧分压和脑血管压力反应性(PRx)的影响,PRx作为脑自动调节的指标。这是一项对12例严重创伤性脑损伤患者进行的前瞻性观察性临床研究,于2002年4月至2005年5月在一家三级神经外科重症监护病房开展。所有患者均接受标准的神经外科重症监护和监测。将颅内压(ICP)、脑温(BT)和脑组织氧合(PTiO2)探头插入(未受挫伤的)外观正常的白质中。脑血管PRx通过ICP与动脉血压之间的动态相关性来测量。当ICP变得难以控制(ICP>20 mmHg)时开始使用巴比妥类药物昏迷治疗。对多模式监测的所有数据进行数字提取并进行统计分析。12例患者中有8例(75%)在使用巴比妥类药物昏迷治疗后平均ICP下降,但只有4例降至20 mmHg以下。在巴比妥类药物治疗前PTiO2水平高于10 mmHg的8例患者中,有6例氧合情况进一步改善。因此,在存活的患者中观察到了ICP、PRx和PTiO2与巴比妥类药物昏迷治疗一致的有利变化。在严重颅脑损伤患者中,通过改善PTiO2和自动调节(PRx)可以检测到对巴比妥类药物的有效反应。